One would expect downregulation rather than upregulation in cancer, because CatB, CatL and CatS have been found to be upregulated in glioma [3], and their expression was found to be correlated with malignancy [4], [6], [8], [41]. Here, TYRP1 is linked to central nervous system cancer.